title: Two for the price of one?
authors.affiliation: Urodoc Ltd., Maryland Ridgeway Road, Herne, Kent CT6 7LN, UK. mike@urodoc.co.uk
authors.forename: Mike
authors.initials: M
authors.lastname: Wyllie
mesh_terms: D058891:5-alpha Reductase Inhibitors; D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use*; D000804:Angiotensin II / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects; D001378:Azasteroids / Q000627:therapeutic use; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects; D004359:Drug Therapy, Combination; D000068538:Dutasteride; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008934:Mitogens / Q000494:pharmacology; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000503:physiopathology*; D044140:Receptor, Angiotensin, Type 1 / Q000627:therapeutic use*; D017154:Stromal Cells / Q000187:drug effects
chemical_list: D058891:5-alpha Reductase Inhibitors; D000316:Adrenergic alpha-Agonists; D001378:Azasteroids; D004791:Enzyme Inhibitors; D008934:Mitogens; D044140:Receptor, Angiotensin, Type 1; D000804:Angiotensin II; D018120:Finasteride; D000068538:Dutasteride